Please assess the completion status of the following clinical trial:

Trial Title: Nebulized Hypertonic Saline for Bronchiolitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* clinical diagnosis of viral bronchiolitis~* between November and April~Exclusion Criteria:~* prematurity \< 34 weeks~* chronic lung disease~* congenital heart disease~* history of wheezing, asthma or albuterol use~* tracheostomy status~* need for intensive care of assisted ventilation

- Gender: ALL
- Minimum Age: None
- Maximum Age: 24 Months
- Healthy Volunteers: f

Study Arms:
- Nebulized 3% Saline (Type: EXPERIMENTAL): 3% NaCl, 4 mL inhalation, up to 3 inhalations every 20 minutes in the ED, and Q8H in the inpatient setting.
- Nebulized 0.9% Saline (Type: PLACEBO_COMPARATOR): 0.9% NaCl, 4 mL inhalation, up to 3 inhalations every 20 minutes in the ED, and Q8H in the inpatient setting.

Based on this trial design, predict the completion outcome and termination type (if applicable).